KALARIS THERAPEUTICS, INC. (KLRS) Operating cash flow 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$38.4MFY2025 · since FY2019: -$20.2M → -$38.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.4M | -85.6% |
| FY2024 | -$20.7M | +83.4% |
| FY2023 | -$124.5M | +12.4% |
| FY2022 | -$142.1M | -33.6% |
| FY2021 | -$106.3M | -74.8% |
| FY2020 | -$60.8M | -201.7% |
| FY2019 | -$20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KLRS financial trends
KLRS RevenueKLRS Net incomeKLRS Net marginKLRS Gross profitKLRS Gross marginKLRS Operating incomeKLRS Operating marginKLRS Free cash flowKLRS Capital expendituresKLRS Return on equityKLRS Stock buybacksKLRS Dividends paidKLRS Total assetsKLRS Total liabilitiesKLRS Shareholders’ equityKLRS overview →